Cargando…

An ex vivo Gene Therapy Approach to Treat Muscular Dystrophy Using inducible Pluripotent Stem Cells

Duchenne muscular dystrophy is a progressive and incurable neuromuscular disease caused by genetic and biochemical defects of the dystrophin-glycoprotein complex. Here we show the regenerative potential of myogenic progenitors derived from corrected dystrophic induced pluripotent stem (iPS) cells ge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Filareto, Antonio, Parker, Sarah, Darabi, Radbod, Borges, Luciene, Iacovino, Michelina, Schaaf, Tory, Mayerhofer, Timothy, Chamberlain, Jeffrey S, Ervasti, James M., McIvor, R. Scott, Kyba, Michael, Perlingeiro, Rita C.R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3595133/ https://www.ncbi.nlm.nih.gov/pubmed/23462992 http://dx.doi.org/10.1038/ncomms2550

Ejemplares similares

A Perspective on the Potential of Human iPS Cell-Based Therapies for Muscular Dystrophies: Advancements so far and Hurdles to Overcome
por: Darabi, Radbod, et al.
Publicado: (2013)

Pax3-induced expansion enables the genetic correction of dystrophic satellite cells
por: Filareto, Antonio, et al.
Publicado: (2015)

Expansion and Purification Are Critical for the Therapeutic Application of Pluripotent Stem Cell-Derived Myogenic Progenitors
por: Kim, Jaemin, et al.
Publicado: (2017)

iPSCs as a Platform for Disease Modeling, Drug Screening, and Personalized Therapy in Muscular Dystrophies
por: Ortiz-Vitali, Jose L., et al.
Publicado: (2019)

Sarcopenic Obesity in Facioscapulohumeral Muscular Dystrophy
por: Vera, Kathryn, et al.
Publicado: (2020)

Corrigendum: Sarcopenic Obesity in Facioscapulohumeral Muscular Dystrophy
por: Vera, Kathryn, et al.
Publicado: (2022)

Pax7 remodels the chromatin landscape in skeletal muscle stem cells
por: Lilja, Karin C., et al.
Publicado: (2017)

Baroreflex sensitivity in facioscapulohumeral muscular dystrophy
por: Anselmo, Miguel, et al.
Publicado: (2022)

Social stress is lethal in the mdx model of Duchenne muscular dystrophy
por: Razzoli, Maria, et al.
Publicado: (2020)

Defective autophagy and increased apoptosis contribute toward the pathogenesis of FKRP-associated muscular dystrophies
por: Ortiz-Cordero, Carolina, et al.
Publicado: (2021)

Transcripts that associate with the RNA binding protein, DEAD-END (DND1), in embryonic stem (ES) cells
por: Zhu, Rui, et al.
Publicado: (2011)

Facioscapulohumeral muscular dystrophy’s game of homeodomains: therapy wants a biomarker as a sword wants a whetstone
por: Kyba, Michael, et al.
Publicado: (2023)

Directed Differentiation of Human Pluripotent Stem Cells toward Skeletal Myogenic Progenitors and Their Purification Using Surface Markers
por: Xu, Nasa, et al.
Publicado: (2021)

LncRNA H19 Alleviates Muscular Dystrophy Through Stabilizing Dystrophin
por: Zhang, Yaohua, et al.
Publicado: (2020)

Induced Pluripotent Stem Cells for Duchenne Muscular Dystrophy Modeling and Therapy
por: Danisovic, Lubos, et al.
Publicado: (2018)

In vitro expanded skeletal myogenic progenitors from pluripotent stem cell-derived teratomas have high engraftment capacity
por: Xie, Ning, et al.
Publicado: (2021)

Efficient engraftment of pluripotent stem cell-derived myogenic progenitors in a novel immunodeficient mouse model of limb girdle muscular dystrophy 2I
por: Azzag, Karim, et al.
Publicado: (2020)

Laminin 411 mediates endothelial specification via multiple signaling axes that converge on β-catenin
por: Hall, Mikayla L., et al.
Publicado: (2022)

Muscular Dystrophy Meets the Gene Chip: New Insights into Disease Pathogenesis
por: Chamberlain, Jeffrey S.
Publicado: (2000)

Recapitulating muscle disease phenotypes with myotonic dystrophy 1 induced pluripotent stem cells: a tool for disease modeling and drug discovery
por: Mondragon-Gonzalez, Ricardo, et al.
Publicado: (2018)

Induced Pluripotent Stem Cells: Hope in the Treatment of Diseases, including Muscular Dystrophies
por: Gois Beghini, Daniela, et al.
Publicado: (2020)

HoxA3 is an apical regulator of hemogenic endothelium
por: Iacovino, Michelina, et al.
Publicado: (2010)

Can Human Pluripotent Stem Cell-Derived Cardiomyocytes Advance Understanding of Muscular Dystrophies?
por: Kalra, Spandan, et al.
Publicado: (2016)

Animal Models for Muscular Dystrophy Show Different Patterns of Sarcolemmal Disruption
por: Straub, Volker, et al.
Publicado: (1997)

p53-independent DUX4 pathology in cell and animal models of facioscapulohumeral muscular dystrophy
por: Bosnakovski, Darko, et al.
Publicado: (2017)

Saying NO to muscular dystrophy
por: Dove, Alan W.
Publicado: (2001)

Fatigue in muscular dystrophies
por: Angelini, Corrado, et al.
Publicado: (2012)

Human induced pluripotent stem cell models for the study and treatment of Duchenne and Becker muscular dystrophies
por: Piga, Daniela, et al.
Publicado: (2019)

Duchenne’s Muscular Dystrophy: The Role of Induced Pluripotent Stem Cells and Genomic Editing on Muscle Regeneration
por: May, Vanessa, et al.
Publicado: (2020)

Induced pluripotent stem cells derived cardiomyocytes from Duchenne Muscular Dystrophy patients in vitro
por: Ghori, Fareeha Faizan, et al.
Publicado: (2021)

Modeling Duchenne Muscular Dystrophy Cardiomyopathy with Patients’ Induced Pluripotent Stem-Cell-Derived Cardiomyocytes
por: Eisen, Binyamin, et al.
Publicado: (2023)

Transplantation studies reveal internuclear transfer of toxic RNA in engrafted muscles of myotonic dystrophy 1 mice
por: Mondragon-Gonzalez, Ricardo, et al.
Publicado: (2019)

Pharmacological TRPC6 inhibition improves survival and muscle function in mice with Duchenne muscular dystrophy
por: Lin, Brian L., et al.
Publicado: (2022)

Cardiac Dysrhythmias, Cardiomyopathy and Muscular Dystrophy in Patients with Emery-Dreifuss Muscular Dystrophy and Limb-Girdle Muscular Dystrophy Type 1B
por: Hong, Jong-Seo, et al.
Publicado: (2005)

Longitudinal Study of Three microRNAs in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
por: Trifunov, Selena, et al.
Publicado: (2020)

Genetic Patterns of Selected Muscular Dystrophies in the Muscular Dystrophy Surveillance, Tracking, and Research Network
por: Kang, Peter B., et al.
Publicado: (2023)

Early pathogenesis of Duchenne muscular dystrophy modelled in patient-derived human induced pluripotent stem cells
por: Shoji, Emi, et al.
Publicado: (2015)

Characteristics of Japanese Patients with Becker Muscular Dystrophy and Intermediate Muscular Dystrophy in a Japanese National Registry of Muscular Dystrophy (Remudy): Heterogeneity and Clinical Variation
por: Mori-Yoshimura, Madoka, et al.
Publicado: (2018)

Comparative proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles: changes contributing to preserve muscle function in Becker muscular dystrophy patients
por: Capitanio, Daniele, et al.
Publicado: (2020)

Studies of pseudohypertrophic muscular dystrophy
por: Bonsett, Charles A., 1921-
Publicado: (1969)

Cannot write session to /tmp/vufind_sessions/sess_fupaqdq8rq83mq7hcu8bmds6s1